TCL Archive Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse October 11, 2013
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Barbara Britt Assumes ONS Presidency, O’Conner Is President-Elect; Kalt Joins NCI May 25, 1990
